United Therapeutics Corp
NASDAQ:UTHR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
United Therapeutics Corp
NASDAQ:UTHR
|
US |
|
I
|
Intorio Corp
OTC:ITOR
|
US |
|
Recce Pharmaceuticals Ltd
ASX:RCE
|
AU |
|
V
|
VeriSign, Inc
XETRA:VRS
|
US |
|
D
|
Defence Therapeutics Inc
CNSX:DTC
|
CA |
|
Nestle SA
F:NESM
|
CH |
|
P
|
Pudo Inc
CNSX:PDO
|
CA |
|
M
|
MDevice Co Ltd
KOSDAQ:226590
|
KR |
|
Geberit AG
SIX:GEBN
|
CH |
|
W
|
Wesfarmers Ltd
F:WF3
|
AU |
|
D
|
DXC Technology Co
SWB:2XT
|
US |
|
Driven Brands Holdings Inc
NASDAQ:DRVN
|
US |
|
Space Shower Skiyaki Holdings Inc
TSE:4838
|
JP |
|
B
|
Balochistan Glass Ltd
KAR:BGL
|
PK |
|
J
|
Japan Exchange Group Inc
F:OSK
|
JP |
|
H
|
HIVE Digital Technologies Ltd
NASDAQ:HIVE
|
CA |
|
B
|
Bankinter SA
SWB:BAKA
|
ES |
|
Andritz AG
F:AZ2
|
AT |
Bankruptcy Probability
United Therapeutics Corp's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
United Therapeutics Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
United Therapeutics Corp
NASDAQ:UTHR
|
22.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
481.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
220.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
127.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
86.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
United Therapeutics Corp's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, United Therapeutics Corp has no debt.
You can find a full breakdown on its Balance Sheet.